100 related articles for article (PubMed ID: 8577209)
1. Staurosporine inhibits the effects of leukotrienes C4 and D4 in isolated guinea pig heart and trachea.
Schäfer S; Walland A
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):469-76. PubMed ID: 8577209
[TBL] [Abstract][Full Text] [Related]
2. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.
Burke JA; Levi R; Guo ZG; Corey EJ
J Pharmacol Exp Ther; 1982 Apr; 221(1):235-41. PubMed ID: 6278136
[TBL] [Abstract][Full Text] [Related]
3. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
4. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
6. Staurosporine inhibits the anaphylactic reaction of the isolated guinea-pig heart.
Schäfer S; Walland A
Eur J Pharmacol; 1994 Jun; 258(3):247-51. PubMed ID: 7522177
[TBL] [Abstract][Full Text] [Related]
7. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
8. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
9. Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart.
Ezra D; Boyd LM; Feuerstein G; Goldstein RE
Am J Cardiol; 1983 May; 51(8):1451-4. PubMed ID: 6303103
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea-pig isolated heart.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Mar; 120(6):1039-48. PubMed ID: 9134215
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man.
Vigorito C; Giordano A; Cirillo R; Genovese A; Rengo F; Marone G
Int J Clin Lab Res; 1997; 27(3):178-84. PubMed ID: 9352380
[TBL] [Abstract][Full Text] [Related]
12. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli.
Gissurarson SR; Sigurdsson SB; Wagner H; Ingolfsdottir K
J Pharmacol Exp Ther; 1997 Feb; 280(2):770-3. PubMed ID: 9023290
[TBL] [Abstract][Full Text] [Related]
13. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions.
Tanaka H; Nagai H; Takeda H; Yamaguchi S; Matsuo A; Inagaki N
Prostaglandins; 1995; 50(5-6):269-85. PubMed ID: 8838238
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of leukotriene D4 on guinea pig tracheal smooth muscle cells: roles of Ca++ influx and intracellular Ca++ release.
Dumitriu D; Prié S; Bernier SG; Guillemette G; Sirois P
J Pharmacol Exp Ther; 1997 Mar; 280(3):1357-65. PubMed ID: 9067324
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism.
Pedersen KE; Bochner BS; Undem BJ
J Pharmacol Exp Ther; 1997 May; 281(2):655-62. PubMed ID: 9152370
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
[TBL] [Abstract][Full Text] [Related]
18. Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit.
Sala A; Rossoni G; Buccellati C; Berti F; Folco G; Maclouf J
Br J Pharmacol; 1993 Nov; 110(3):1206-12. PubMed ID: 8298810
[TBL] [Abstract][Full Text] [Related]
19. Role of Leukotriene-degrading enzymes in pulmonary response to antigen infusion in sensitized guinea pigs in vivo.
Funayama T; Sekizawa K; Yamaya M; Yamauchi K; Ohno I; Ohrui T; Terajima M; Okinaga S; Sasaki H
Am J Respir Cell Mol Biol; 1996 Aug; 15(2):260-7. PubMed ID: 8703483
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
